Fact CheckerSign in

NCT06269029Completed

Chest Mobility Exercises Versus Proprioceptive Neuromuscular Facilitation in Patients With COPD

Effect of Chest Mobility Exercises Versus Proprioceptive Neuromuscular Facilitation in Patients With Chronic Obstructive Pulmonary Disease

Source: ClinicalTrials.gov · Last updated 22 Jul 2024

Brief summary (registry, in English)

Chest mobility exercise versus proprioceptive neuromuscular facilitation in patients with chronic obstructive pulmonary disease

Status (registry)
Completed
Study type
Interventional
Enrollment
60 (actual)
First submitted
17 Jan 2024
Start date
17 Feb 2024
Primary completion date
30 Jun 2024
Lead sponsor
Cairo University
Diseases
COPD
NCT number
NCT06269029

What you commit to

  • Study type: Interventional
  • Participants enrolled: 60
  • From 17 Feb 2024 to the primary completion date, 30 Jun 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Tracheal surgery or sternotomy in the last 15 days.

Other illness

  • Severe psychiatric or cognitive impairments.
  • Progressive neuromuscular disorders.
  • Deep-venous thrombosis (to minimize risk for pulmonary embolism from being in a prone position.

Other

  • Patients with the following criteria will excluded from the study:
  • Decreased level of consciousness.
  • Unstable fracture.
  • pacemaker inserted for fewer than 2 days
  • Mean arterial blood pressure of less than 65 mm Hg with or without vasopressors.
  • Massive haemoptysis.
  • Intracranial pressure of more than 30 mm Hg or cerebral perfusion pressure of less than 60 mm Hg.

Who the study is looking for

  • All patients will have the following criteria:
  • Age: 50-60 years old
  • All patients will be in mild to moderate of COPD. In accordance with criteria of Global Initiative for Chronic Obstructive Lung Disease (GOLD) (GOLD I-II).
  • BMI: obese class 1 (30-34.9).
  • Sex: male
  • They suffered from mild dyspnea, chronic cough and expectorations, with forced expiratory volume in one second (FEV1sec) from 50% to 80% of predicted value.

Age in the registry: 50 years to 60 years · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Cairo University; Faculty of Physical Therapy
Coordinator of this site? Confirm its status
CairoEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.